Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 6/20 | 0.47 |
| ▸ | CDK2 | P24941 | 6/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.36 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.36 |
| ▸ | RORC | P51449 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13289252 | 0.95 | GSK3B (0.46) | GSK3BCDK2POLBALDH1A1MAPT | |
| SCHEMBL13289118 | 0.91 | GSK3B (0.56) | GSK3BCDK2POLBALDH1A1MAPT | |
| SCHEMBL13289272 | 0.91 | GSK3B (0.48) | GSK3BCDK2POLBALDH1A1MAPT | |
| SCHEMBL13289126 | 0.91 | GSK3B (0.47) | GSK3BCDK2POLBALDH1A1MAPT | |
| SCHEMBL13289053 | 0.91 | CDK2 (0.53) | GSK3BCDK2POLBALDH1A1MAPT | |
| SCHEMBL13289384 | 0.90 | GSK3B (0.47) | GSK3BCDK2POLBALDH1A1MAPT | |
| SCHEMBL13121213 | 0.90 | GSK3B (0.59) | GSK3BCDK2POLBCCNA2CCNA1 | |
| SCHEMBL13289344 | 0.90 | GSK3B (0.46) | GSK3BCDK2POLBALDH1A1MAPT | |
| SCHEMBL13289109 | 0.89 | GSK3B (0.46) | GSK3BCDK2POLBALDH1A1MAPT | |
| SCHEMBL13288997 | 0.89 | ALDH1A1 (0.49) | GSK3BCDK2POLBALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2194058-A1 | Pyrazolopyrimidines suitable for the treatment of cancer diseases | SCHERING CORPORATION (US) | 2010-06-09 | — | — | EP | disclosed |